Tejara Capital LTD Heron Therapeutics, Inc. Transaction History
Tejara Capital LTD
- $275 Billion
- Q2 2024
A detailed history of Tejara Capital LTD transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Tejara Capital LTD holds 4,187,860 shares of HRTX stock, worth $8.88 Million. This represents 5.33% of its overall portfolio holdings.
Number of Shares
4,187,860
Previous 4,411,567
5.07%
Holding current value
$8.88 Million
Previous $12.2 Billion
19.95%
% of portfolio
5.33%
Previous 4.49%
Shares
7 transactions
Others Institutions Holding HRTX
# of Institutions
198Shares Held
129MCall Options Held
94.7KPut Options Held
148K-
Rubric Capital Management LP New York, NY26.7MShares$56.6 Million2.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.62MShares$18.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$17.6 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.6MShares$16.1 Million0.05% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$14.8 Million58.47% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $252M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...